Chiral Chromatography Columns Industry

The global chiral chromatography columns market size was estimated at USD 105.5 million in 2023 and is projected to grow at a CAGR of 4.3% from 2024 to 2030. Prominent factors facilitating the growth of the market are technological advancements in the chromatography instruments. For instance, in February 2022, Sartorius acquired Novasep’s chromatography division after receiving approval from the U.S. Federal Trade Commission. The acquired portfolio includes chromatography systems designed for smaller biomolecules such as, insulin, oligonucleotides, and peptides along with advanced systems for continuous biologics manufacturing.

Moreover, increasing R&D investments in the pharmaceutical and biotechnology industry is also fueling the market growth. Pharmaceutical and biotechnology companies are investing significantly in research to develop new protein-related products for healthcare needs. Technologies such as chromatography, radiopharmaceuticals and targeted therapies are crucial for protein separation and identification during drug discovery and development processes.

Gather more insights about the market drivers, restrains and growth of the Global Chiral Chromatography Columns market

Chiral Chromatography Columns Market Report Segmentation

• Type Outlook (Revenue, USD Million, 2018 - 2030)
  • High Performance Liquid Chromatography Columns
  • Gas Chromatography Columns
  • Solid Phase Extraction Columns
• Product Outlook (Revenue, USD Million, 2018 - 2030)
  • Pre-packed Columns
  • Empty Columns
• Material Outlook (Revenue, USD Million, 2018 - 2030)
  • Metal Based
  • Glass Based
  • Plastic Based
• End Use Outlook (Revenue, USD Million, 2018 - 2030)
  • Pharmaceutical & Biotechnology
  • Academic & Research Institutes
  • Hospital and Diagnostic Clinics
  • Environmental Testing Laboratories
  • Food & Beverage Industry
  • Cosmetic
  • Nutraceutical
• Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Key Chiral Chromatography Columns Company Insights:

Some of the key players operating in the market include Agilent Technologies, Inc., GE Healthcare, Danaher, Thermo Fisher Scientific, Inc., among others.

• Veolia Water Technologies is an American company dealing in the space of life science and clinical research area. The company offers chromatography columns for HPLC and UPLC systems which include chiral chromatography columns.
• Danaher Corporation, a company based in Washington, U.S. dealing in biotechnology, diagnostics, and life sciences. The company offers chromatography columns via Life Science business across the world.

Daicel Corporation, Perkin Elmer, Bio-Rad Laboratories, are some of the emerging market participants in the chiral chromatography columns market.

• Perkin Elmer is a global company engaged in analytical instruments, and consumables for multiple markets. The company’s offering also includes chiral chromatography columns in pre-packaged format.
• Bio-Rad Laboratories is a manufacturer of pre-packed and empty chromatography columns. The company also deals in multiple markets related to life sciences research and clinical diagnostics field.

Key Chiral Chromatography Columns Companies:

The following are the leading companies in the chiral chromatography columns market. These companies collectively hold the largest market share and dictate industry trends.

• Agilent Technologies, Inc.
• Waters Corporation
• Thermo Fisher Scientific, Inc.
• Merck & Co., Inc
• Cytiva
• Danaher
• GE Healthcare
• Shimadzu Corporation
• Daicel Corporation
• Bio-Rad Laboratories
• Perkin Elmer

Recent Developments

• In May 2024, Advanced Materials Technology (AMT) launched its HALO Elevate C18, which represents a significant advancement in the field of high-performance liquid chromatography (HPLC). This new stationary phase offers exceptional high pH stability and selectivity, addressing key challenges faced by chromatographers in various analytical applications.
• In August 2023, Waters Corporation launched the XBridge Premier GTx BEH SEC columns specifically designed for gene therapy applications. These new columns are aimed at addressing the unique challenges faced in gene therapy research and development, offering high performance and reliability.

Order a free sample PDF of the Chiral Chromatography Columns Market Intelligence Study, published by Grand View Research.